Your shopping cart is currently empty

MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $871 | Inquiry | Inquiry |
| Description | MT1, a bivalent chemical probe targeting BET bromodomains, demonstrates an IC50 value of 0.789 nM for BRD4(1). |
| In vitro | MT1 (100 nM, 24 h) prominently induces apoptosis in MV4;11 cells via caspase-3 and PARP pathways, evidenced by substantial caspase-3 and PARP cleavage in Western Blot Analysis [1]. |
| In vivo | MT1, administered intraperitoneally at doses of 44.2 and 22.1 μmol/kg daily for 14 days, significantly delayed the progression of leukemia in mice (Mus musculus) in comparison to the control, JQ1. Additionally, MT1 demonstrated a terminal half-life (t 1/2) of 2.70 hours in mice. In the context of leukemia xenograft models, this regimen markedly reduced the leukemic burden over the study period when compared to either the vehicle or JQ1. |
| Molecular Weight | 1134.2 |
| Formula | C54H66Cl2N10O9S2 |
| Cas No. | 2060573-82-0 |
| Smiles | Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)NCCOCCOCCOCCOCCOCCOCCOCCNC(=O)C[C@@H]1N=C(c3c(C)c(C)sc3-n3c(C)nnc13)c1ccc(Cl)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.